Clinical Pharmacologist
CSL Behring
King of Prussia, Pennsylvania, United States
Disclosure information not submitted.
Phase 1 Study of the Safety and Pharmacokinetics of CSL889 (Hemopexin) in Adults with SCD
Saturday, June 8, 2024
9:00 AM – 9:15 AM ET